Amlodipine enhances amelioration of vascular insulin resistance, oxidative stress, and metabolic disorders by candesartan in metabolic syndrome rats | Zendy

Daisuke Sueta | Zendy; Taishi Nakamura | Zendy; YiFei Dong | Zendy; Keiichiro Kataoka | Zendy; Nobutaka Koibuchi | Zendy; Eiichiro Yamamoto | Zendy; Kensuke Toyama | Zendy; Osamu Yasuda | Zendy; Hisao Ogawa | Zendy; Shokei KimMitsuyama | Zendy

Open Access

Amlodipine enhances amelioration of vascular insulin resistance, oxidative stress, and metabolic disorders by candesartan in metabolic syndrome rats

Author(s) -

Daisuke Sueta,

Taishi Nakamura,

YiFei Dong,

Keiichiro Kataoka,

Nobutaka Koibuchi,

Eiichiro Yamamoto,

Kensuke Toyama,

Osamu Yasuda,

Hisao Ogawa,

Shokei KimMitsuyama

Publication year - 2012

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1038/ajh.2012.26

Subject(s) - candesartan , medicine , metabolic syndrome , insulin resistance , oxidative stress , amlodipine , endocrinology , diabetes mellitus , insulin , blood pressure , angiotensin ii

The pharmacological advantage of combination of an angiotensin receptor blocker (ARB) and a calcium-channel blocker (CCB) is not fully defined. This study was undertaken to elucidate the potential benefit of their combination in metabolic syndrome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research